Official Statistics

Case-mix adjusted percentage cancers diagnosed at stages 1 and 2 by CCG in England

One-year and 3-year case-mix adjusted percentage of cancers diagnosed at stages 1 and 2, as compared to stages 1 to 4, by Clinical Commissioning Group for 21 cancer groups.

• From: Public Health England
• Published: 29 May 2020

Documents

National Disease Registration Service: Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 in England, by Clinical Commissioning Group

Ref: PHE publications gateway number: GW-1047

HTML

Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 for Clinical Commissioning Groups in England (experimental statistics), diagnosed 2013 to 2018

Ref: PHE publications gateway number: GW-1047

ODS, 2.96 MB

This file is in an OpenDocument format

National Disease Registration Service: Clinical Commissioning Groups in England (experimental statistics)

Ref: PHE publications gateway number: GW-1047

PDF, 796 KB, 23 pages

Pre-release access list: Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 in England, by Clinical Commissioning Group

Ref: PHE publications gateway number: GW-1047

HTML

Details

This publication sets out and comments on stage at cancer diagnosis in Clinical Commissioning Groups in England for patients diagnosed in the period 2013 to 2018. Proportion of cancers diagnosed at an early stage are presented unadjusted and adjusted for case-mix (age, sex, cancer site and socio-economic deprivation). Supporting data quality and stage completeness are presented for persons diagnosed 2001 to 2018.

The 21 cancer groups are defined as those with 1,500 cancers diagnosed annually in England and 70% staging completeness.

The statistics are obtained from the National Cancer Registration Dataset that is collected, quality assured and analysed by the National Cancer Registration and Analysis Service, part of Public Health England.

Published 29 May 2020